Evidence map›Paper›PMID 28280859›Full record

ReviewDer Radiologe2017

[CT and MRI of the liver: when, what, why?]

J Budjan, S O Schoenberg, U I Attenberger

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Radiologe, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

J BudjanInstitut für Klinische Radiologie und Nuklearmedizin, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland. johannes.budjan@umm.de.
S O SchoenbergInstitut für Klinische Radiologie und Nuklearmedizin, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland.
U I AttenbergerInstitut für Klinische Radiologie und Nuklearmedizin, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland.
Heidelberg University · DEUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The detection and differential diagnostic clarification of liver pathologies play an important role in almost all medical disciplines. Because of its superior soft tissue contrast, the availability of liver-specific contrast agents and functional techniques, magnetic resonance imaging (MRI) is the method of choice for the diagnostics of focal and diffuse liver pathologies. In addition to its superior detection and differentiation capabilities, MRI can provide prognostic information and enable early assessment of the therapy response for malignant liver lesions using functional techniques, especially diffusion imaging. Computed tomography (CT) is the imaging method of choice for the detection of traumatic liver injury. Despite the increasing availability of functional techniques in CT, MRI remains the overall modality of choice in liver imaging.

Indexed as

Magnetic Resonance ImagingTomography, X-Ray ComputedContrast MediaHumansLiverLiver DiseasesLiver NeoplasmsPrognosisContrast MediaDifferential diagnosticsDiffusion imagingFocal liver lesionsLiver imagingPrognosis estimation

Identifiers

PMID28280859
OpenAlexW2592117930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.